JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB8416

Anti-DR5 antibody

4

(5 Reviews)

|

(64 Publications)

Rabbit Polyclonal DR5 antibody. Suitable for ICC, WB, IHC-P and reacts with Human, Mouse, Rat samples. Cited in 64 publications. Immunogen corresponding to Synthetic Peptide within Human TNFRSF10B.

View Alternative Names

CD262, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9, UNQ160/PRO186, TNFRSF10B, Tumor necrosis factor receptor superfamily member 10B, Death receptor 5, TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2

9 Images
Immunocytochemistry - Anti-DR5 antibody (AB8416)
  • ICC

Supplier Data

Immunocytochemistry - Anti-DR5 antibody (AB8416)

ICC analysis of 4% paraformaldehyde-fixed (room temperature for 10 minutes) HeLa cells labeling DR5 with ab8416 at 20μg/mL, followed by goat anti-rabbit IgG antibody (Alexa Fluor 488) at 1/500 dilution (green).

Blocking condition : 5% BSA, room temperature for 1 hour.

Primary antibody incubation : 4°C overnight.

Secondary antibody incubation : room temperature for 1 hour.

Washing condition : PBS, 3 x 3 minutes

Immunocytochemistry - Anti-DR5 antibody (AB8416)
  • ICC

Unknown

Immunocytochemistry - Anti-DR5 antibody (AB8416)

ab8416 at 5μg/ml staining DR5 in Hela cells by ICC. Cells were fixed with formaldehyde and blocked with 10% serum for 1 hour at room termperature. Antigen retrieval was by heat mediation with a Citrate buffer (pH 6). Overnight primary antibody at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DR5 antibody (AB8416)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DR5 antibody (AB8416)

IHC-P of 4% paraformaldehyde-fixed rat brain tissue labelled DR5 with ab8416 at 5μg/ml, followed by Goat Anti-Rabbit IgG secondary antibody at 1/5000 dilution (green) and DAPI (blue).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DR5 antibody (AB8416)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DR5 antibody (AB8416)

Immunohistochemical analysis of 4% paraformaldehydefixed mouse kidney tissue using anti-DR5 antibody (ab8416) at 20μg/mL followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DR5 antibody (AB8416)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DR5 antibody (AB8416)

Immunohistochemical analysis of paraffin-embedded mouse kidney tissue using anti-DR5 antibody (ab8416) at 5μg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation (microwave for 20 minutes) with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4˚C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary at room temperature for 1 hour. Counter stained with Hematoxylin.

Endogenous peroxidase blocking : 3% H202 at room temperature for 10 minutes.

Washing : PBS, 2 x 5 minutes.

Western blot - Anti-DR5 antibody (AB8416)
  • WB

Supplier Data

Western blot - Anti-DR5 antibody (AB8416)

All lanes:

Western blot - Anti-DR5 antibody (ab8416) at 0.5 µg/mL

Lane 1:

HEK293 cell lysate at 15 µg

Lane 2:

A431 cell lysate at 15 µg

Lane 3:

A549 cell lysate at 15 µg

Lane 4:

Caco-2 cell lysate at 15 µg

Lane 5:

Daudi cell lysate at 15 µg

Lane 6:

HeLa cell lysate at 15 µg

Lane 7:

HepG2 cell lysate at 15 µg

Lane 8:

K562 cell lysate at 15 µg

Lane 9:

MCF7 cell lysate at 15 µg

Lane 10:

Jurkat cell lysate at 15 µg

Lane 11:

SK-N-SH cell lysate at 15 µg

Lane 12:

THP-1 cell lysate at 15 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG HRP conjugate at 1/10000 dilution

Predicted band size: 47 kDa

false

Western blot - Anti-DR5 antibody (AB8416)
  • WB

Supplier Data

Western blot - Anti-DR5 antibody (AB8416)

Blocking buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-DR5 antibody (ab8416) at 1 µg/mL

All lanes:

Rat Skeletal Muscle at 15 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG HRP Conjugate at 1/10000 dilution

Predicted band size: 47 kDa

false

Western blot - Anti-DR5 antibody (AB8416)
  • WB

Supplier Data

Western blot - Anti-DR5 antibody (AB8416)

All lanes:

Western blot - Anti-DR5 antibody (ab8416) at 1 µg

Lane 1:

3T3/NIH cell lysate at 15 µg

Lane 2:

C2C12 cell lysate at 15 µg

Secondary

All lanes:

Goat anti-Rabbit IgG HRP conjugate at 1/10000 dilution

Predicted band size: 47 kDa

false

Western blot - Anti-DR5 antibody (AB8416)
  • WB

CiteAb

Western blot - Anti-DR5 antibody (AB8416)

DR5 western blot using anti-DR5 antibody ab8416. Publication image and figure legend from Yang, Y., Zhang, P., et al., 2018, Front Pharmacol, PubMed 29946260.

ab8416 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab8416 please see the product overview.

Effect of SCG on protein expression of TRAIL, DR5, FASL, FAS, IL-33, and caspase-3 in Con A-treated mice. (A) The expression of TRAIL. (B) The expression of DR5. (C) The expression of IL-33. (D) The expression of FASL. (E) The expression of FAS. (F) The expression of cleaved caspase-3. Data were expressed as mean ± SD (n = 3). **p < 0.01 compared with normal group; #p < 0.05, ##p < 0.01 compared with model group.

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, IHC-P, ICC

applications

Immunogen

Synthetic Peptide within Human TNFRSF10B. The exact immunogen used to generate this antibody is proprietary information.

O14763

Specificity

Does not cross react with DR4.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "5 µg/mL", "ICC-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "2 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Mouse": { "ICC-species-checked": "guaranteed", "ICC-species-dilution-info": "", "ICC-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "2 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p>" }, "Rat": { "ICC-species-checked": "guaranteed", "ICC-species-dilution-info": "", "ICC-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "2 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

For information on sample preparation for western blot, please refer here.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

DR5 also known as Death Receptor 5 TRAIL-R2 or TNFRSF10B is a protein critical in apoptosis. It is a transmembrane receptor with a mass of approximately 54 kDa. Researchers find it expressed mostly in tissues such as lung colon and prostate. DR5 functions by binding to its ligand TRAIL triggering the extrinsic apoptotic pathway. Through this mechanism DR5 initiates a cascade of caspase activation that leads to cell death.
Biological function summary

DR5 plays a significant role in the regulation of apoptosis particularly in cancer cells. It is a component of the TRAIL receptor complex which includes several other death receptors like DR4. This complex formation allows DR5 to mediate apoptotic signals more efficiently. By controlling apoptosis DR5 helps maintain tissue homeostasis and prevents abnormal cell proliferation.

Pathways

DR5 is an important part of the TRAIL signaling pathway and the extrinsic apoptosis pathway. It connects with proteins like FADD and Caspase-8 essential in the apoptotic signaling cascade. By interacting with these proteins DR5 drives the progression of the apoptotic signal ensuring the removal of dysfunctional cells. Such pathways are vital for restraining tumor development and progression.

DR5 exhibits significant relevance to cancer and autoimmune diseases. Its ability to induce apoptosis through the TRAIL pathway keeps oncogenic transformations in check. In cancer DR5 often interfaces with other proteins like Bcl-2 which are involved in cell survival. Furthermore defects or aberrant expressions in DR5 have associations with autoimmune disorders where excessive cell death or survival contributes to disease pathology. DR5's role in these conditions makes it a promising target in therapeutic strategies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor for the cytotoxic ligand TNFSF10/TRAIL (PubMed : 10549288). The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappa-B. Essential for ER stress-induced apoptosis.
See full target information TNFRSF10B

Publications (64)

Recent publications for all applications. Explore the full list and refine your search

Animals : an open access journal from MDPI 15: PubMed40564269

2025

The Anticancer Effect of Genistein Through Enhancing PERK Signaling and Suppressing the IRE1α-XBP1 Axis in Canine Mammary Gland Tumor Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Ye-Ji Jang,Min-Jae Yoo,Hyuk Jang,Jun Song,Sang-Youel Park,Jawun Choi,Jae-Won Seol

Regenerative therapy 30:1-8 PubMed40476159

2025

Transplantation of chemically induced liver progenitors in Nagase analbuminemic rats under liver regenerative stimulus.

Applications

Unspecified application

Species

Unspecified reactive species

Masayuki Fukumoto,Akihiko Soyama,Daisuke Miyamoto,Takanobu Hara,Hajime Matsushima,Hajime Imamura,Mampei Yamashita,Tomohiko Adachi,Kengo Kanetaka,Susumu Eguchi

Cell reports. Medicine 6:102158 PubMed40449480

2025

Combined therapy with DR5-targeting antibody-drug conjugate and CDK inhibitors as a strategy for advanced colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Dongdong Zhou,Er'jiang Tang,Wenjun Wang,Youban Xiao,Jianming Huang,Jie Liu,Chao Zheng,Kai Zhang,Ruxia Hu,Feiqi Wang,Peng Xiong,Xin Chu,Weisong Li,Dongqin Liu,Xiangfu Zeng,Dexian Zheng,Liefeng Wang,Yong Zheng,Shuyong Zhang

Current issues in molecular biology 46:10880-10895 PubMed39451526

2024

Gintonin-Enriched Extract Fraction Sensitizes Renal Carcinoma Cells to TRAIL-Induced Apoptosis through DR4/5 Upregulation.

Applications

Unspecified application

Species

Unspecified reactive species

Seongwoo Hong,Rami Lee,Gyun Seok Park,Sumin Han,Juhyun Shin,Yoon-Mi Lee,Seung-Yeol Nah,Jae-Wook Oh

World journal of gastrointestinal oncology 16:2716-2726 PubMed38994171

2024

Sm-like 5 knockdown inhibits proliferation and promotes apoptosis of colon cancer cells by upregulating p53, CDKN1A and TNFRSF10B.

Applications

Unspecified application

Species

Unspecified reactive species

Cai-Jing Mo,Xiao-Yuan Deng,Ru-Lan Ma,Kun Zhu,Lei Shi,Kang Li

Biomedicines 12: PubMed38791085

2024

The Association of Death Receptors and TGF-β1 Expression in Urothelial Bladder Cancer and Their Prognostic Significance.

Applications

Unspecified application

Species

Unspecified reactive species

Slavica Stojnev,Irena Conic,Ana Ristic Petrovic,Ivan Petkovic,Milica Radic,Miljan Krstic,Ljubinka Jankovic Velickovic

FEBS open bio 13:2375-2388 PubMed37879960

2023

Death receptor 5 promotes tumor progression in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Junbing Chen,Lin Li,Longtao Huangfu,Hong Du,Xin Ji,Xiaofang Xing,Jiafu Ji

Pharmaceuticals (Basel, Switzerland) 16: PubMed37895919

2023

Oxaliplatin Enhances the Apoptotic Effect of Mesenchymal Stem Cells, Delivering Soluble TRAIL in Chemoresistant Colorectal Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Adriana G Quiroz-Reyes,Paulina Delgado-González,José F Islas,Adolfo Soto-Domínguez,Carlos A González-Villarreal,Gerardo R Padilla-Rivas,Elsa N Garza-Treviño

Frontiers in pharmacology 14:1171293 PubMed37274104

2023

Blocking TRAIL-DR5 signaling pathway with soluble death receptor 5 fusion protein mitigates radiation-induced injury.

Applications

Unspecified application

Species

Unspecified reactive species

Danyang Zhao,Lei Yang,Peng Han,Haihui Zhang,Fanjun Wang,Zhiyun Meng,Hui Gan,Zhuona Wu,Wenzhong Sun,Chuan Chen,Guifang Dou,Ruolan Gu

International journal of biological sciences 19:2648-2662 PubMed37324949

2023

Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting Prodrug.

Applications

Unspecified application

Species

Unspecified reactive species

Jen-Chih Tseng,Jing-Xing Yang,Chia-Yin Lee,Chen-Fu Lo,Yi-Ling Liu,Mingzi M Zhang,Li-Rung Huang,Ko-Jiunn Liu,Chien-Chia Wang,Chi-Ying F Huang,Yi-Ren Hong,Lun K Tsou,Tsung-Hsien Chuang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com